Skip to end of metadata
Go to start of metadata





1a. Project Name

BRIDG 2020 Update

1b. Project ID

1574

1c. Is Your Project an Investigative Project (aka PSS-Lite)?

No

1d. Is your Project Artifact being Reaffirmed or proceeding to Normative directly after being either Informative or STU?

No

1e. Today's Date

1f. Name of standard being reaffirmed

1g. Project Artifact Information

1h. ISO/IEC Standard to Adopt

1i. Does the standard include excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption?

1j. Unit of Measure

2a. Primary/Sponsor WG

Biomedical Research & Regulation

2d. Project Facilitator

Smita Hastak

2e. Other Interested Parties (and roles)

2f. Modeling Facilitator

Wendy Ver Hoef

2g. Publishing Facilitator

Myron Finseth

2h. Vocabulary Facilitator

Julie James

2i. Domain Expert Representative

HL7 BR&R Members, CDISC, NCI and FDA domain experts

2j. Business Requirements Analyst

2k. Conformance Facilitator

2l. Other Facilitators

2m. Implementers

3a. Project Scope

Changes are made to the BRIDG model based on work planned by FDA and NCI - we know there will be work, but at this point we are unclear what that will be. It will be similar in scope to that of previous releases. As an illustration BRIDG 5.3 was concerned with adding imaging semantics and updating a mapping; 5.2 was concerned with updates for anatomic pathology and specimen DAM modelling. The full release history is here: https://bridgmodel.nci.nih.gov/bridg-news#bridgrelease5.3.1. Any work of a greater scope than previously seen will be subject to separate approval.

Attachments

3b. Project Need

The BRIDG model is subject to an annual revision - this PSS covers the revision in 2020

3c. Security Risk

No

3d. External Drivers

3e. Objectives/Deliverables and Target Dates

Ballot for May 2020 ballot resolution
Publish Autumn 2020

3f. Common Names / Keywords / Aliases:

BRIDG, BRIDG Model, Biomedical Research Integrated Domain Group Model

3g. Lineage

New model version will replace previous model version.

3h. Project Dependencies

3i. HL7-Managed Project Document Repository URL:

https://confluence.hl7.org/display/BRR/BRIDG+Model

3j. Backwards Compatibility

Yes

3k. Additional Backwards Compatibility Information (if applicable)

3l. Using Current V3 Data Types?

Yes

3l. Reason for not using current V3 data types?

3m. External Vocabularies

3n. List of Vocabularies

3o. Earliest prior release and/or version to which the compatibility applies

BRIDG 5.3.1

4a. Products

Domain Analysis Model (DAM)

4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?

4c. FHIR Profiles Version

4d. Please define your New Product Definition

4d. Please define your New Product Family

5a. Project Intent

Revise current standard

5a. White Paper Type

5a. Is the project adopting/endorsing an externally developed IG?

5a. Externally developed IG is to be (select one)

5a. Specify external organization

5a. Revising Current Standard Info

BRIDG 5.3.1

5b. Project Ballot Type

Informative

5c. Additional Ballot Info

5d. Joint Copyright

No

5e. I understand I must submit a Joint Copyright Letter of Agreement to the TSC in order for the PSS to receive TSC approval.

no

6a. External Project Collaboration

6b. Content Already Developed

6c. Content externally developed?

No

6d. List Developers of Externally Developed Content

6e. Is this a hosted (externally funded) project?

6f. Stakeholders

Regulatory Agency, Standards Development Organizations (SDOs)

6f. Other Stakeholders

6g. Vendors

Pharmaceutical, EHR, PHR, Health Care IT, Clinical Decision Support Systems, Lab, HIS, Other

6g. Other Vendors

Clinical Research Organisations

6h. Providers

6h. Other Providers

6i. Realm

Universal

7d. US Realm Approval Date

7a. Management Group(s) to Review PSS

7b. Sponsoring WG Approval Date

Oct 01, 2019

7c. Co-Sponsor Approval Date

7c. Co-Sponsor 2 Approval Date

7c. Co-Sponsor 3 Approval Date

7c. Co-Sponsor 4 Approval Date

7c. Co-Sponsor 5 Approval Date

7c. Co-Sponsor 6 Approval Date

7c. Co-Sponsor 7 Approval Date

7c. Co-Sponsor 8 Approval Date

7c. Co-Sponsor 9 Approval Date

7c. Co-Sponsor 10 Approval Date

7e. CDA MG Approval Date

7f. FMG Approval Date

7g. V2 MG Approval Date

7h. Architecture Review Board Approval Date

7i. Steering Division Approval Date

Oct 29, 2019

7j. TSC Approval Date